TrialVascular health and risk management2011

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.

Daniel Duprez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.